Special Article
Current State of Biosimilars in Mexico: The Position of the Mexican College of Rheumatology, 2016
Escenario actual de los medicamentos biocomparables en México: posicionamiento del Colegio Mexicano de Reumatología, 2016
Daniel Xibillea,b, Sandra Carrillob,c, Gabriela Huerta-Sild, Ramiro Hernándeze, Leonardo Limónb,f, Guadalupe Olvera-Sotog, Luis Javier Jara-Quezadag, Abdieel Esquivelh, Marcela Pérez-Rodríguezg,i,
a Jefatura de Investigación y Capacitación, Servicios de Salud del Estado de Morelos, Mexico
b Colegio Mexicano de Reumatología, Mexico City, Mexico
c Departamento de Reumatología, Hospital Primero de Octubre, Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado (ISSSTE), Mexico City, Mexico
d Departamento de Reumatología, Hospital General de México, Mexico City, Mexico
e Departamento de Reumatología, UMAE Hospital de Especialidades, Centro Médico Nacional Siglo XXI (CMNSXXI), Instituto Mexicano del Seguro Social (IMSS), Mexico City, Mexico
f Departamento de Reumatología, Hospital Central Norte PEMEX, Mexico City, Mexico
g Unidad de Investigación, Colegio Mexicano de Reumatología, Mexico City, Mexico
h Dirección de Proyectos de Investigación en Farmacología, Grupo I&I Pharma S. C., Mexico City, Mexico
i Coordinación de Investigación, Instituto Mexicano del Seguro Social (IMSS), Mexico City, Mexico
Ver másRead
8568
Timeswas read the article
2408
Total PDF
6160
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 6 | 4 | 2 | 6 |
| 2025 5 | 238 | 67 | 305 |
| 2025 4 | 210 | 42 | 252 |
| 2025 3 | 172 | 39 | 211 |
| 2025 2 | 140 | 59 | 199 |
| 2025 1 | 162 | 41 | 203 |
| 2024 12 | 120 | 47 | 167 |
| 2024 11 | 133 | 51 | 184 |
| 2024 10 | 95 | 31 | 126 |
| 2024 9 | 117 | 35 | 152 |
| 2024 8 | 99 | 45 | 144 |
| 2024 7 | 93 | 44 | 137 |
| 2024 6 | 106 | 50 | 156 |
| 2024 5 | 118 | 40 | 158 |
| 2024 4 | 97 | 31 | 128 |
| 2024 3 | 112 | 29 | 141 |
| 2024 2 | 78 | 23 | 101 |
| 2024 1 | 87 | 35 | 122 |
| 2023 12 | 73 | 25 | 98 |
| 2023 11 | 59 | 36 | 95 |
| 2023 10 | 78 | 37 | 115 |
| 2023 9 | 193 | 39 | 232 |
| 2023 8 | 65 | 18 | 83 |
| 2023 7 | 71 | 26 | 97 |
| 2023 6 | 55 | 26 | 81 |
| 2023 5 | 94 | 25 | 119 |
| 2023 4 | 61 | 13 | 74 |
| 2023 3 | 123 | 31 | 154 |
| 2023 2 | 102 | 28 | 130 |
| 2023 1 | 96 | 25 | 121 |
| 2022 12 | 148 | 27 | 175 |
| 2022 11 | 90 | 33 | 123 |
| 2022 10 | 129 | 40 | 169 |
| 2022 9 | 73 | 31 | 104 |
| 2022 8 | 92 | 44 | 136 |
| 2022 7 | 67 | 44 | 111 |
| 2022 6 | 111 | 54 | 165 |
| 2022 5 | 114 | 41 | 155 |
| 2022 4 | 145 | 46 | 191 |
| 2022 3 | 107 | 60 | 167 |
| 2022 2 | 97 | 42 | 139 |
| 2022 1 | 107 | 43 | 150 |
| 2021 12 | 113 | 46 | 159 |
| 2021 11 | 138 | 62 | 200 |
| 2021 10 | 112 | 60 | 172 |
| 2021 9 | 65 | 37 | 102 |
| 2021 8 | 66 | 45 | 111 |
| 2021 7 | 67 | 37 | 104 |
| 2021 6 | 103 | 47 | 150 |
| 2021 5 | 61 | 67 | 128 |
| 2021 4 | 158 | 152 | 310 |
| 2021 3 | 100 | 55 | 155 |
| 2021 2 | 71 | 36 | 107 |
| 2021 1 | 75 | 22 | 97 |
| 2020 12 | 73 | 27 | 100 |
| 2020 11 | 87 | 21 | 108 |
| 2020 10 | 59 | 20 | 79 |
| 2020 9 | 72 | 30 | 102 |
| 2020 8 | 43 | 22 | 65 |
| 2020 7 | 36 | 17 | 53 |
| 2020 6 | 50 | 23 | 73 |
| 2020 5 | 38 | 19 | 57 |
| 2020 4 | 21 | 13 | 34 |
| 2020 3 | 19 | 4 | 23 |
| 2020 2 | 1 | 0 | 1 |
| 2019 5 | 1 | 0 | 1 |
| 2018 6 | 0 | 1 | 1 |
Show all
